$STBA

S&T Bancorp Inc (STBA) (Q3 2026) Earnings Call Highlights: Record EPS and Revenue

S&T Bancorp (STBA) reported Q3 2026 earnings with record EPS and revenue, but loan balances and deposits declined. Loan growth is expected to slow due to disciplined underwriting. Net interest margin is anticipated to stay above 4% into 2027. The company paused share buybacks but may resume them in Q4. Management discussed M&A priorities, Durbin impact, and credit trends. Non-interest income is projected to be steady, with expenses managed at a 3% increase for 2027.

Original reporting
Published Oct 23, 2026, 1:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
S&T Bancorp Inc (STBA) (Q3 2026) Earnings Call Highlights: Record EPS and Revenue — source image
Decision brief

The 30-second read

$STBANeutralHigh
01

Why it matters

The guidance suggests limited earnings growth, which could pressure the stock unless the buyback resumption materializes.

02

Market read

Earnings and guidance for a US‑listed regional bank; immediate relevance for traders focused on banking sector momentum.

03

What to watch

Potential upside from the $100M buyback authorization and a possible resumption of repurchases in Q4.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

S&T Bancorp is a regional bank focused on commercial and C&I lending. The call highlighted flat loan balances, modest deposit declines, and a cautious outlook for loan growth through 2027.

Company-level read

Ticker impact

$STBANeutralHigh confidence
Context

Earnings call disclosed record Q3 EPS and revenue, flat loan growth guidance, slowed loan origination, modest deposit decline, and a $100M buyback authorization with potential resumption in Q4.

Expected impact

likely modest downside as investors price in slower loan growth and flat loan balances.

Evidence & confidence

The disclosed guidance reduces growth expectations and signals limited margin expansion, which typically pressures the stock in the short term.

Market effects

Signals a slowdown in regional community banking loan growth, potentially pressuring peer C&I lenders.

May weigh on Mid‑West and Midwest regional banks with similar loan mix.

Limited; primarily a US regional banking story.

Counterpoint

Buy on the dip if the bank can maintain net interest margin above 4% despite slower loan growth.

Key entities

  • David Antolik

    President, provided commentary on loan growth strategy and net interest margin.

  • Chris McComish

    CEO, discussed M&A priorities and capital thresholds.

  • Mark Kochvar

    CFO, detailed deposit cost trends, NIM outlook, and buyback authorization.

Related articles

$STBAMed

S&T Bancorp (STBA) Q3 2026 Earnings Call Transcript

S&T Bancorp (STBA) reported Q3 2026 earnings with net interest margin expanding to 4.06% and revenue growth outpacing expense growth. Loan balances were flat, but average loan and deposit balances increased. Tangible book value per share rose to $29.28. The company maintained strong asset quality and expects continued margin expansion with potential rate increases. They plan to upgrade their mobile banking platform in Q4 and anticipate flat to low single-digit loan growth.

$STBAMed

S&T Bancorp Q3 Earnings Call Highlights

S&T Bancorp reported Q3 2026 with revenue growth outpacing expenses, improving efficiency ratio to 54.65%. Loan growth was modest, with commercial real estate up $65M but commercial and industrial down $50M. Deposits saw seasonal decline, but asset quality remained strong. The company paused share buybacks and expects low-single-digit asset growth. Management emphasized underwriting discipline and inorganic growth opportunities.

$STBAMed

S&T Bancorp (STBA) stock is up, what you need to know

S&T Bancorp (STBA) shares rose 4.1% after reporting Q3 2026 earnings of $1.09 per share, beating estimates. Revenue was $107.79M, up from $106.72M expected. Net income increased to $38.6M. The company cited higher loan yields and share buybacks as contributors to the growth. CEO Chris McComish highlighted record earnings and revenue. Shares traded at $51, near the 52-week high of $53.36.

$STBAMed

S&T Bancorp’s (NASDAQ:STBA) Q3 2026 sales beat estimates

S&T Bancorp (STBA) reported Q3 2026 sales exceeding estimates, with net interest income comprising 87.6% of total revenue over five years. TBVPS grew at 7% annually over five years but slowed to 5.9% recently. EPS beat expectations, while net interest income narrowly outperformed estimates. TBVPS slightly missed forecasts. The stock price remained unchanged at $48.86 post-results.